Patient Guide: Global, Multicenter Study of AMT-116 Versus Investigator's Choice in Participants With Advanced or Metastatic Non-squamous EGFR-Wildtype Non-Small Cell Lung Cancer (NSCLC) With Progression on or After Platinum-Based Chemotherapy and Anti-PD-1/PD-L1 Immunotherapy

We'll Help You Connect with This Trial

Quri.ai is a free clinical trial matching service. We help patients like you connect directly with research sites conducting this study.

  • Get matched to the right study location for you
  • Connect directly with study coordinators at 5 participating sites
  • Understand eligibility with our simplified screening tool
  • Free service - we're here to help you access clinical research
Trial ID: NCTNCT07718737
Status: UPCOMING
Condition: NSCLC (Advanced Non-small Cell Lung Cancer)
Phase: Phase II, Phase III

Find a Study Location Near You

This study is available at 5 research sites. We'll help you connect with the location that's right for you.

Participating sites include:
  • Coffs Harbour,
  • Melbourne,
  • Melbourne,
  • • And 2 more locations - let us help you find the closest one

Loading interactive enrollment tools...

The full interactive experience will load momentarily